Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis.

Documenti analoghi

• Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis.
  di: Hood, L, et al.
  Pubblicazione: (1991)
• Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
  di: Sharma, S D, et al.
  Pubblicazione: (1991)
• Peptide immunotherapy in experimental autoimmune encephalomyelitis
  di: Stephen M Anderton
  Pubblicazione: (2015-06-01)
• A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis.
  di: Topham, D J, et al.
  Pubblicazione: (1994)
• Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis.
  di: Schiffenbauer, J, et al.
  Pubblicazione: (1993)